Nadexam (Indapamide, Amlodipine Besilate)

Indapamide, the active ingredient in Nadexam, is a combination antihypertensive (thiazide‑like diuretic plus calcium channel blocker) presented as an oral tablet for oral use. It is employed to lower elevated blood pressure in adult patients with hypertension.

GNH USA supplies Nadexam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards, provides regulatory documentation for global distribution, and manufactures the product under EU GMP guidelines.

Nadexam is a fixed‑dose combination that targets the hypertension pathway to achieve blood‑pressure control.

Hypertension: reduces elevated systolic and diastolic pressure in adults with essential hypertension. Essential hypertension: provides additional control when monotherapy is insufficient. Isolated systolic hypertension: helps achieve target systolic values in older patients.

Nadexam may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Dizziness or light‑headedness - Headache - Peripheral edema, especially of the ankles - Flushing or warmth sensation - Fatigue or tiredness - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Severe hypotension leading to fainting - Electrolyte disturbances such as low potassium - Acute renal dysfunction or worsening of existing kidney disease - Angioedema or severe swelling of face, lips, or throat - Hepatic injury manifested by jaundice or elevated liver enzymes - Severe skin reactions, including Stevens‑Johnson syndrome

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

Monitor blood pressure regularly: adjust therapy if target levels are not reached. Assess renal function: check serum creatinine and eGFR before and during treatment. Check electrolytes: especially potassium and sodium levels. Use caution in severe hepatic impairment: dose adjustment may be required. Elderly patients: start at lower doses and monitor for orthostatic hypotension. Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Nadexam can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Lithium: risk of lithium toxicity increases. - NSAIDs (e.g., ibuprofen, naproxen): may blunt diuretic effect and raise renal risk. - Potassium‑sparing diuretics (e.g., spironolactone): can cause hyperkalaemia. - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): raise amlodipine plasma concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: additive blood‑pressure lowering effect; monitor for hypotension. - Beta‑blockers: may enhance hypotensive response. - Digoxin: amlodipine can increase digoxin levels; watch for toxicity.